Hot Blue Chip Stocks To Invest In 2023

When it comes to selecting dividend stocks to buy, investors can take their pick: high yield stocks, blue chip stocks with safe payouts, stocks with high dividend growth rates, value stocks; the list goes on.

But selecting undervalued dividend stocks is particularly advantageous for a variety of reasons, not the least of which is that dividend yield is higher when a stock’s price is lower, as they move inversely.

Here are 3 undervalued dividend stocks to buy for high total returns:

Triton International (NYSE:TRTN) Perrigo Company (NYSE:PRGO) LyondellBasell Industries (NYSE:LYB)

A low valuation also means a better chance for higher capital appreciation (in addition to the income received) when that undervalued stock sees its valuation multiples rise.

Dividend Stocks to Buy: Triton International (TRTN) Source: VladSV /

Our first stock is Triton International, a company that acquires, leases and sells intermodal containers and chassis to shipping lines, manufacturers and freight forwarders. Triton leases many types of containers including tanks, specialty, dry and refrigerated. It also trades in containers, buying and selling on the open market.

Hot Blue Chip Stocks To Invest In 2023: TrovaGene, Inc.(TROV)

We are a molecular diagnostic company that focuses on the development and commercialization of a proprietary molecular diagnostic technology for use in disease detection and monitoring across a variety of medical disciplines. Our primary internal focus is to leverage our novel cell-free molecular diagnostic platform to facilitate improvements in the field of oncology, while our external focus includes entering into license agreements or collaborations to develop our technology in areas such as infectious disease, transplant medicine and prenatal genetics. We are leveraging our proprietary molecular diagnostic technology for the detection of cell-free DNA originating from diseased cell death that can be isolated and detected from urine, blood, and tissue samples to improve disease management.   Advisors’ Opinion:

  • [By Stephan Byrd]

    TrovaGene Inc (NASDAQ:TROV) shares saw strong trading volume on Thursday . 1,477,200 shares were traded during trading, an increase of 185% from the previous session’s volume of 517,912 shares.The stock last traded at $0.83 and had previously closed at $0.81.

  • [By Logan Wallace]

    Media stories about TrovaGene (NASDAQ:TROV) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. TrovaGene earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news coverage about the medical research company an impact score of 45.974011377318 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    Here are some of the news stories that may have impacted Accern’s rankings:

    Get TrovaGene alerts:

    Average True Range under Consideration: TrovaGene, Inc. (NASDAQ:TROV), USD Partners LP (NYSE:USDP), Tiptree … ( Take These As A Wake-Up Call: TrovaGene, Inc. (NASDAQ:TROV), PPDAI Group Inc. (NYSE:PPDF), Inseego Corp … ( Review of Financial analysis: TrovaGene, Inc., (NASDAQ: TROV), Redwood Trust, Inc., (NYSE: RWT) ( In which scenario TrovaGene, Inc. (TROV) and Urban Outfitters, Inc. (URBN) are Trading Now? ( Analysts’ Views: Sumitomo Mitsui Financial Group Inc (SMFG) and Trovagene Inc (TROV) (

    TROV has been the topic of several recent research reports. Maxim Group reiterated a “hold” rating on shares of TrovaGene in a report on Monday, March 5th. HC Wainwright reiterated a “buy” rating and set a $12.00 target price on shares of TrovaGene in a report on Tuesday, March 6th. ValuEngine cut shares of TrovaGene from a “sell” rating to a “strong sell” rating in a report on Monday, April 2nd. Finally, Zacks Investment Research cut shares of TrovaGene from a “buy” rating to a “hold” rating in a report on Thursday, May 3rd. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. TrovaGene currently has an average rating of “Buy” and a consensus target price of $19.17.

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) fell more than 55% Friday to post a new 52-week low of $0.79 after closing at $1.77 on Thursday. The 52-week high is $19.56. Volume of around 11 million was nearly five times the daily average of about 230,000. The company announced a public offering of $18 million in stock and warrants priced at $1.00 for the unit.

Hot Blue Chip Stocks To Invest In 2023: Investors Real Estate Trust(IRET)

Investors Real Estate Trust, a real estate investment trust (REIT), engages in the ownership and operation of income-producing real estate properties in the United States. It owns multi-family residential properties and commercial office, medical, industrial, and retail properties located primarily in the upper midwest states of Minnesota and North Dakota. As of April 30, 2008, the company operated a real estate portfolio of 72 multi-family residential; 65 office; 48 medical; 17 industrial; and 33 retail properties. Investors Real Estate Trust has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, the trust is not subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1970 and is headquartered in Minot, North Dakota with additional offices in Minneapolis, Minnesota, and Omaha, Nebraska; and Kansas City, Kansas, and St. Louis, Missouri.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Investors Real Estate Trust Reit (IRET)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Motley Fool Transcribing]

    Investors Real Estate Trust (NYSE:IRET) Q1 2019 Earnings Conference CallSep. 11, 2018 10:00 a.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on INVESTORS REAL ESTATE TRUST REIT Common Stock (IRET)

    For more information about research offerings from Zacks Investment Research, visit

Hot Blue Chip Stocks To Invest In 2023: Fiesta Restaurant Group, Inc.(FRGI)

Fiesta Restaurant Group, Inc., through its subsidiaries, owns, operates, and franchises fast-casual restaurants. It operates its fast-casual restaurants under the Pollo Tropical and Taco Cabana brand names. The company’s Pollo Tropical restaurants offer various Caribbean inspired food, and Taco Cabana restaurants offer a selection of Mexican food. As of January 3, 2016, it had 155 company-owned Pollo Tropical restaurants, 162 company-owned Taco Cabana restaurants, and 35 franchised Pollo Tropical restaurants in the U.S., Puerto Rico, the Bahamas, Guatemala, Honduras, Panama, Trinidad & Tobago, and Venezuela, as well as 6 franchised Taco Cabana restaurants in the U.S. The company was incorporated in 2011 and is headquartered in Addison, Texas.

Leave a Reply

Your email address will not be published.